---
title: "Caplin Point Laboratories' Fiscal Q3 Consolidated Profit Rises"
date: "2025-02-07 17:08:51"
summary: "Caplin Point Laboratories' consolidated profit rose to 1.39 billion Indian rupees in the fiscal third quarter that ended Dec. 31, 2024, from 1.17 billion rupees a year ago. Earnings per share stood at 18.19 rupees, compared with the year-ago figure of 15.39 rupees, according to a Friday filing to the..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Caplin Point Laboratories' consolidated profit rose to 1.39 billion Indian rupees in the fiscal third quarter that ended Dec. 31,Â 2024, from 1.17 billion rupees a year ago.

Earnings per share stood at 18.19 rupees, compared with the year-ago figure of 15.39 rupees, according to a Friday filing to the Indian stock exchanges by the pharmaceutical company.

Revenue from operations in fiscal Q3 edged up to 4.93 billion rupees from 4.36 billion rupees a year earlier.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250207:G2465037:0/)
